Prosthetic Valves and Postoperative Evaluation
Key Takeaways
- Patient-prosthesis mismatch (PPM) is graded by indexed effective orifice area: aortic PPM is moderate at 0.65-0.85 cm^2/m^2 and severe below 0.65 cm^2/m^2; mitral PPM is moderate at 0.9-1.2 cm^2/m^2 and severe at or below 0.9 cm^2/m^2.
- A normal mechanical aortic prosthesis has a mean gradient under 20 mmHg and a dimensionless velocity index (DVI) of 0.30-0.35; severe obstruction shows a mean gradient over 35 mmHg and a DVI under 0.25.
- A normal prosthetic mitral valve has a mean gradient under 5-6 mmHg and a pressure half-time under 130 ms; severe obstruction shows a mean gradient over 10 mmHg and a pressure half-time over 200 ms.
- Small, symmetric 'washing jets' are a normal, expected finding on mechanical valves and must be distinguished from pathologic paravalvular regurgitation, which is typically eccentric and located outside the sewing ring.
- Obstructive thrombus is usually visualized as a mobile mass on TEE with associated leaflet restriction on fluoroscopy, whereas pannus is a later, fixed fibrous ingrowth that is frequently not visualized as a discrete mass.
Mechanical vs. Bioprosthetic Valves
Prosthetic valves fall into two broad categories with different echocardiographic expectations:
| Feature | Mechanical | Bioprosthetic |
|---|---|---|
| Common designs | Bileaflet (most common today), tilting-disc, caged-ball (older/rare) | Stented porcine/pericardial, stentless, transcatheter (TAVR) |
| Durability | Excellent, rarely degenerates structurally | Structural valve deterioration typically over 10-20 years |
| Anticoagulation | Lifelong warfarin required (target INR varies by position/thrombogenicity) | Not required long-term (beyond an initial post-op period) |
| Typical patient | Younger, low bleeding risk | Older, or anticoagulation contraindicated |
| Normal color Doppler jets | Small, symmetric 'washing' jets through the closure mechanism are expected and normal | Trivial central regurgitation may be normal; any jet should be small and central |
The mechanical valve's normal washing jets are a critical distinction from pathology: they are typically multiple, small, symmetric, and central to the sewing ring. Any regurgitant jet that is eccentric or located outside the sewing ring is paravalvular and abnormal until proven otherwise.
Normal vs. Abnormal Gradients
Prosthetic valve gradients are flow- and heart-rate dependent, so reference values are compared against a patient's own post-operative baseline whenever available. Representative normal and severe-obstruction values:
| Position | Parameter | Normal | Severe Obstruction |
|---|---|---|---|
| Aortic | Mean gradient | <20 mmHg | >35 mmHg |
| Aortic | Dimensionless velocity index (DVI) | 0.30-0.35 | <0.25 |
| Aortic | Effective orifice area | Valve/size-specific | <0.8 cm^2 |
| Mitral | Mean gradient | <5-6 mmHg | >10 mmHg |
| Mitral | Pressure half-time (PHT) | <130 ms | >200 ms |
| Mitral | Peak velocity | — | >2.5 m/s |
DVI (LVOT VTI divided by prosthetic-valve VTI) is especially useful for the aortic position because it is independent of LVOT diameter measurement error and remains valid even when the exact valve size/type is unknown.
Prosthetic Valve Dysfunction
Four mechanisms account for most acquired prosthetic dysfunction:
- Thrombosis — typically early post-implant, associated with subtherapeutic anticoagulation; TEE shows a mobile, often soft echo-density mass, and fluoroscopy/cine typically shows restricted leaflet motion in nearly all cases.
- Pannus — fibrous tissue ingrowth that develops later after implantation; frequently produces leaflet restriction without a discrete TEE-visible mass, and is not treated with fibrinolysis.
- Structural degeneration (bioprosthetic) — leaflet calcification, tearing, or perforation causing stenosis, regurgitation, or both; evaluated the same way as native leaflet disease.
- Dehiscence — partial separation of the sewing ring from the annulus; produces an abnormal 'rocking' motion of the prosthesis (rocking greater than 15 degrees is considered hemodynamically significant) and a new paravalvular regurgitant jet.
| Feature | Thrombus | Pannus |
|---|---|---|
| Onset after implant | Early | Late |
| Anticoagulation history | Often subtherapeutic | Often therapeutic |
| TEE mass visualization | Usually present, soft echo-density | Often absent or subtle |
| Fluoroscopic leaflet restriction | Nearly always present | Variable |
| Treatment | Fibrinolysis or reoperation | Surgery only (fibrinolysis contraindicated) |
Patient–Prosthesis Mismatch (PPM)
PPM occurs when a normally functioning prosthesis is simply too small for the patient's body size, so its effective orifice area (EOA) cannot accommodate the necessary cardiac output without generating elevated gradients. Severity is graded by indexed EOA (EOA divided by body surface area):
| Position | None | Moderate | Severe |
|---|---|---|---|
| Aortic | >0.85 cm^2/m^2 | 0.65-0.85 cm^2/m^2 | <0.65 cm^2/m^2 |
| Mitral | >1.2 cm^2/m^2 | 0.9-1.2 cm^2/m^2 | <=0.9 cm^2/m^2 |
PPM is a leading cause of persistently elevated gradients after valve replacement even when the prosthesis itself is structurally and functionally normal — it must be distinguished from true valve obstruction (thrombosis, pannus, degeneration), which shows abnormal leaflet motion or structure rather than a preserved but undersized orifice. Because mechanical mitral prostheses generate significant acoustic shadowing on TTE, TEE is often required to fully assess the left atrial side of a mitral prosthesis for thrombus, vegetation, or paravalvular leak that TTE cannot resolve.
Surveillance and Reporting
Every prosthetic valve evaluation should begin from a documented early post-operative baseline study, typically obtained in the first several weeks after implantation once acute hemodynamic changes have stabilized, with subsequent surveillance studies (often annual, or sooner if new symptoms develop) compared directly against that baseline rather than against generic population reference values. A rising gradient trend over serial studies is a more reliable dysfunction signal than any single absolute measurement, since valve size, cardiac output, and patient body size all shift the 'normal' range for a given prosthesis.
A complete prosthetic valve report should include valve type and position, peak and mean gradients, DVI or EOA, any regurgitation (its severity and whether it is central/expected versus eccentric/paravalvular), and a qualitative assessment of leaflet or disc motion. Transcatheter aortic valves (TAVR) follow the same Doppler framework as surgical bioprostheses, with the added consideration of frame stent geometry and a higher relative frequency of mild paravalvular regurgitation immediately post-implant, which typically requires the same eccentric-jet-location logic used for surgical paravalvular leak. When gradients are discordant with clinical status, or when DVI and mean gradient disagree about severity, stress echocardiography or CT can help separate true structural obstruction from a flow-related or measurement artifact.
A mechanical aortic prosthesis has a mean gradient of 42 mmHg and a dimensionless velocity index (DVI) of 0.18. These findings are most consistent with:
A patient's mitral bioprosthesis has an indexed effective orifice area (iEOA) of 0.8 cm^2/m^2 but shows normal leaflet motion and structure on TEE. This finding is best classified as: